| 期 |
栏目 |
标题 |
文件 |
| 卷 80, 编号 5 (2008) |
Editorial |
Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection |
|
| 卷 81, 编号 6 (2009) |
Editorial |
Prevalence of mental disorders in SLE patients: correlations with the disease activity and comorbid chronic conditions |
|
| 卷 81, 编号 6 (2009) |
Editorial |
Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis |
|
| 卷 81, 编号 5 (2009) |
Editorial |
Prophylaxis of cardiovascular diseases in rheumatoid arthritis |
|
| 卷 86, 编号 5 (2014) |
Editorial |
Cardiovascular diseases in patients with rheumatoid arthritis during long-term methotrexate therapy |
|
| 卷 87, 编号 5 (2015) |
Editorial |
Left and right ventricular diastolic dysfunction in patients with early rheumatoid arthritis before prescribing disease-modifying antirheumatic therapy |
|
| 卷 87, 编号 5 (2015) |
Editorial |
Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases |
|
| 卷 88, 编号 5 (2016) |
Editorial |
Cardiovascular disease in rheumatic diseases |
(Rus)
|
| 卷 88, 编号 5 (2016) |
Editorial |
N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs |
(Rus)
|
| 卷 88, 编号 5 (2016) |
Editorial |
Interleukin-6 inhibition and cardiovascular disease in patients with rheumatoid arthritis |
(Rus)
|
| 卷 88, 编号 5 (2016) |
Editorial |
Cardiovascular risk in patients with psoriatic arthritis |
(Rus)
|
